CN111568864A - 一种提高溶解度的硫酸黏菌素可溶性粉及其制备方法和应用 - Google Patents
一种提高溶解度的硫酸黏菌素可溶性粉及其制备方法和应用 Download PDFInfo
- Publication number
- CN111568864A CN111568864A CN202010482792.6A CN202010482792A CN111568864A CN 111568864 A CN111568864 A CN 111568864A CN 202010482792 A CN202010482792 A CN 202010482792A CN 111568864 A CN111568864 A CN 111568864A
- Authority
- CN
- China
- Prior art keywords
- parts
- colistin sulfate
- sulfate
- colistin
- powder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108010078777 Colistin Proteins 0.000 title claims abstract description 71
- 229960001127 colistin sulfate Drugs 0.000 title claims abstract description 66
- ZESIAEVDVPWEKB-ORCFLVBFSA-N n-[(2s)-4-amino-1-[[(2s,3r)-1-[[(2s)-4-amino-1-oxo-1-[[(3s,6s,9s,12s,15r,18s,21s)-6,9,18-tris(2-aminoethyl)-3-[(1r)-1-hydroxyethyl]-12,15-bis(2-methylpropyl)-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]amino]butan-2-yl]amino]-3-h Chemical compound OS(O)(=O)=O.OS(O)(=O)=O.CC(C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@H]([C@@H](C)O)CN[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCN)NC1=O.CCC(C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@H]([C@@H](C)O)CN[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCN)NC1=O ZESIAEVDVPWEKB-ORCFLVBFSA-N 0.000 title claims abstract description 66
- 239000000843 powder Substances 0.000 title claims abstract description 50
- 238000002360 preparation method Methods 0.000 title claims abstract description 14
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims abstract description 63
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 29
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims abstract description 25
- 239000008101 lactose Substances 0.000 claims abstract description 25
- 229940093429 polyethylene glycol 6000 Drugs 0.000 claims abstract description 23
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 claims abstract description 21
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims abstract description 21
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims abstract description 21
- 239000001267 polyvinylpyrrolidone Substances 0.000 claims abstract description 21
- KPQJOKRSYYJJEL-VLQRKCJKSA-K [Na+].[Na+].CC1(C)[C@H](CC[C@@]2(C)[C@H]1CC[C@]1(C)[C@@H]2C(=O)C=C2[C@@H]3C[C@](C)(CC[C@]3(C)CC[C@@]12C)C([O-])=O)O[C@H]1O[C@@H]([C@@H](O)[C@H](O)[C@H]1O[C@@H]1O[C@@H]([C@@H](O)[C@H](O)[C@H]1O)C([O-])=O)C([O-])=O Chemical compound [Na+].[Na+].CC1(C)[C@H](CC[C@@]2(C)[C@H]1CC[C@]1(C)[C@@H]2C(=O)C=C2[C@@H]3C[C@](C)(CC[C@]3(C)CC[C@@]12C)C([O-])=O)O[C@H]1O[C@@H]([C@@H](O)[C@H](O)[C@H]1O[C@@H]1O[C@@H]([C@@H](O)[C@H](O)[C@H]1O)C([O-])=O)C([O-])=O KPQJOKRSYYJJEL-VLQRKCJKSA-K 0.000 claims abstract description 19
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 claims abstract description 16
- IFGCUJZIWBUILZ-UHFFFAOYSA-N sodium 2-[[2-[[hydroxy-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyphosphoryl]amino]-4-methylpentanoyl]amino]-3-(1H-indol-3-yl)propanoic acid Chemical compound [Na+].C=1NC2=CC=CC=C2C=1CC(C(O)=O)NC(=O)C(CC(C)C)NP(O)(=O)OC1OC(C)C(O)C(O)C1O IFGCUJZIWBUILZ-UHFFFAOYSA-N 0.000 claims abstract description 11
- 229960004799 tryptophan Drugs 0.000 claims abstract description 8
- 239000003814 drug Substances 0.000 claims abstract description 6
- 239000000203 mixture Substances 0.000 claims description 27
- 229960004106 citric acid Drugs 0.000 claims description 16
- 238000002156 mixing Methods 0.000 claims description 9
- 239000012153 distilled water Substances 0.000 claims description 8
- 238000001694 spray drying Methods 0.000 claims description 8
- 238000003756 stirring Methods 0.000 claims description 6
- 238000005303 weighing Methods 0.000 claims description 6
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 claims description 5
- 229940124350 antibacterial drug Drugs 0.000 claims description 4
- 235000019333 sodium laurylsulphate Nutrition 0.000 claims 4
- 238000000034 method Methods 0.000 claims 3
- 230000000844 anti-bacterial effect Effects 0.000 claims 1
- 239000006184 cosolvent Substances 0.000 abstract description 6
- 229960003346 colistin Drugs 0.000 abstract description 5
- JORAUNFTUVJTNG-BSTBCYLQSA-N n-[(2s)-4-amino-1-[[(2s,3r)-1-[[(2s)-4-amino-1-oxo-1-[[(3s,6s,9s,12s,15r,18s,21s)-6,9,18-tris(2-aminoethyl)-3-[(1r)-1-hydroxyethyl]-12,15-bis(2-methylpropyl)-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]amino]butan-2-yl]amino]-3-h Chemical compound CC(C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@H]([C@@H](C)O)CN[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCN)NC1=O.CCC(C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@H]([C@@H](C)O)CN[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCN)NC1=O JORAUNFTUVJTNG-BSTBCYLQSA-N 0.000 abstract description 5
- XDJYMJULXQKGMM-UHFFFAOYSA-N polymyxin E1 Natural products CCC(C)CCCCC(=O)NC(CCN)C(=O)NC(C(C)O)C(=O)NC(CCN)C(=O)NC1CCNC(=O)C(C(C)O)NC(=O)C(CCN)NC(=O)C(CCN)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CCN)NC1=O XDJYMJULXQKGMM-UHFFFAOYSA-N 0.000 abstract description 5
- KNIWPHSUTGNZST-UHFFFAOYSA-N polymyxin E2 Natural products CC(C)CCCCC(=O)NC(CCN)C(=O)NC(C(C)O)C(=O)NC(CCN)C(=O)NC1CCNC(=O)C(C(C)O)NC(=O)C(CCN)NC(=O)C(CCN)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CCN)NC1=O KNIWPHSUTGNZST-UHFFFAOYSA-N 0.000 abstract description 5
- 239000002253 acid Substances 0.000 abstract description 3
- 239000000945 filler Substances 0.000 abstract description 3
- 235000003599 food sweetener Nutrition 0.000 abstract description 3
- 150000007524 organic acids Chemical class 0.000 abstract description 3
- 235000019629 palatability Nutrition 0.000 abstract description 3
- 239000002904 solvent Substances 0.000 abstract description 3
- 239000004094 surface-active agent Substances 0.000 abstract description 3
- 239000003765 sweetening agent Substances 0.000 abstract description 3
- 241000287828 Gallus gallus Species 0.000 description 19
- 235000013330 chicken meat Nutrition 0.000 description 19
- 208000024891 symptom Diseases 0.000 description 10
- 230000000052 comparative effect Effects 0.000 description 8
- 230000036528 appetite Effects 0.000 description 5
- 235000019789 appetite Nutrition 0.000 description 5
- 230000001575 pathological effect Effects 0.000 description 5
- 229940079593 drug Drugs 0.000 description 4
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 230000002550 fecal effect Effects 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 2
- 241000194105 Paenibacillus polymyxa Species 0.000 description 2
- 239000003651 drinking water Substances 0.000 description 2
- 235000020188 drinking water Nutrition 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 108010040201 Polymyxins Proteins 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229960001375 lactose Drugs 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 239000003910 polypeptide antibiotic agent Substances 0.000 description 1
- 244000144977 poultry Species 0.000 description 1
- 235000013594 poultry meat Nutrition 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
完全溶解所需时间 | |
实施例1 | 60s |
实施例2 | 58s |
实施例3 | 63s |
对比例1 | 5min |
对比例2 | 7min |
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010482792.6A CN111568864B (zh) | 2020-06-01 | 2020-06-01 | 一种提高溶解度的硫酸黏菌素可溶性粉及其制备方法和应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010482792.6A CN111568864B (zh) | 2020-06-01 | 2020-06-01 | 一种提高溶解度的硫酸黏菌素可溶性粉及其制备方法和应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN111568864A true CN111568864A (zh) | 2020-08-25 |
CN111568864B CN111568864B (zh) | 2022-06-24 |
Family
ID=72125547
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010482792.6A Active CN111568864B (zh) | 2020-06-01 | 2020-06-01 | 一种提高溶解度的硫酸黏菌素可溶性粉及其制备方法和应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111568864B (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108210881A (zh) * | 2016-12-13 | 2018-06-29 | 河南后羿实业集团有限公司 | 一种硫酸黏菌素可溶性粉及其制备方法 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010086339A1 (en) * | 2009-01-30 | 2010-08-05 | Andersen, S. A. | Process for the preparation of colistin medicated feeds and feeds obtainable by said process |
CN104397361A (zh) * | 2014-12-12 | 2015-03-11 | 无锡正大畜禽有限公司 | 一种饲料用纳米级硫酸粘杆菌素预混剂的制备方法 |
CN105617353A (zh) * | 2016-01-04 | 2016-06-01 | 李志海 | 一种黏菌素口服给药组合物 |
CN108853024A (zh) * | 2018-07-27 | 2018-11-23 | 洛阳瑞华动物保健品有限公司 | 一种硫酸黏菌素可溶性粉及其制备方法 |
-
2020
- 2020-06-01 CN CN202010482792.6A patent/CN111568864B/zh active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010086339A1 (en) * | 2009-01-30 | 2010-08-05 | Andersen, S. A. | Process for the preparation of colistin medicated feeds and feeds obtainable by said process |
CN104397361A (zh) * | 2014-12-12 | 2015-03-11 | 无锡正大畜禽有限公司 | 一种饲料用纳米级硫酸粘杆菌素预混剂的制备方法 |
CN105617353A (zh) * | 2016-01-04 | 2016-06-01 | 李志海 | 一种黏菌素口服给药组合物 |
CN108853024A (zh) * | 2018-07-27 | 2018-11-23 | 洛阳瑞华动物保健品有限公司 | 一种硫酸黏菌素可溶性粉及其制备方法 |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108210881A (zh) * | 2016-12-13 | 2018-06-29 | 河南后羿实业集团有限公司 | 一种硫酸黏菌素可溶性粉及其制备方法 |
CN108210881B (zh) * | 2016-12-13 | 2021-06-11 | 河南后羿实业集团有限公司 | 一种硫酸黏菌素可溶性粉及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN111568864B (zh) | 2022-06-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2934480B1 (en) | Germicidal compositions comprising carboxylic acid mixture and use as topical disinfectants | |
EP2775838B1 (en) | Aqueous antimicrobial composition containing coniferous resin acids | |
CN104840426B (zh) | 一种阿莫西林可溶性粉及其制备方法和应用 | |
Hassan et al. | Innovative drugs, chemicals, and enzymes within the animal production chain | |
CN111568864B (zh) | 一种提高溶解度的硫酸黏菌素可溶性粉及其制备方法和应用 | |
CN110892947A (zh) | 一种禽用复合酸化剂及其制备方法和应用 | |
CN101829082B (zh) | 一种兽用盐酸大观霉素、盐酸林可霉素注射液的制备方法 | |
CN112972379A (zh) | 一种加米霉素乳剂及制备方法与在防治猪回肠炎方面的应用 | |
CN117815181B (zh) | 一种牛羊腐蹄病蹄部喷涂剂及其制备方法与应用 | |
CN109316473A (zh) | 一种水溶性单分子植物精油及其制备方法 | |
CN101744815B (zh) | 奥美拉唑钠的组合药物 | |
CN101129409A (zh) | 一种抗真菌类外用药 | |
CN108272756B (zh) | 一种阿莫西林可溶性粉及其制备方法 | |
CN105902499B (zh) | 恩诺沙星可溶性粉及其制备方法 | |
CN101461783B (zh) | 可静脉注射的硫酸奈替米星纳米胶束制剂及其制备方法 | |
CN111134127A (zh) | 禽舍用恩康唑喷雾剂及其制备方法 | |
CN115501328A (zh) | 一种薁磺酸钠壳聚糖凝胶及其制备工艺 | |
RU2432945C1 (ru) | Ветеринарная композиция для профилактики и лечения различных форм эндометрита, содержащая пропранолол в сочетании с антибактериальным компонентом, и ветеринарное лекарственное средство для профилактики и лечения различных форм эндометрита | |
KR100636888B1 (ko) | 산붕괴코팅제로 코팅된 브로멜라인 및 브로멜라인의코팅방법 | |
RU2762088C1 (ru) | Способ лечения мастита у коров | |
CN109481491B (zh) | 诃子组合物及其在制备用于预防和/或治疗猪呼吸系统疾病的产品中的应用 | |
CN117797238A (zh) | 一种稳定的复方硝酸咪康唑溶液的制备工艺及其应用 | |
CN117100729B (zh) | 一种私处抑菌组合物、私处护理产品及其制备方法和应用 | |
CN108310370A (zh) | 一种兽用有机酸和酶复方乳房注入剂及其制备方法 | |
CN107982275A (zh) | 甘露大糖在妇科抗菌产品中的应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240205 Address after: Building 0026, G48, East Side of Tai Road and North Side of Xinyang Road, China Pharmaceutical City, Taizhou Medical High tech Industrial Development Zone, Jiangsu Province, 225316 Patentee after: Jiangsu Dafang Biotechnology Co.,Ltd. Country or region after: China Address before: 211111 No.1-2, Wangyuan Road, moling Industrial Park, Jiangning District, Nanjing City, Jiangsu Province Patentee before: NANJING DAFANG BIOENGINEERING Co.,Ltd. Country or region before: China |